SGLT2 Inhibitors in Acute Heart Failure: A Meta-Analysis of Randomized Controlled Trials

Acute heart failure (AHF) is a major public health concern, affecting 26 million worldwide. Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a class of glucose-lowering drugs, comprising canagliflozin, dapagliflozin, and empagliflozin that are being explored for AHF. We aim to meta-analyze the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ul Amin, Noor, Sabir, Faiza, Amin, Talal, Sarfraz, Zouina, Sarfraz, Azza, Robles-Velasco, Karla, Cherrez-Ojeda, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778112/
https://www.ncbi.nlm.nih.gov/pubmed/36553880
http://dx.doi.org/10.3390/healthcare10122356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9778112/
https://www.ncbi.nlm.nih.gov/pubmed/36553880
http://dx.doi.org/10.3390/healthcare10122356

Ejemplares similares